NCT06557512
- Conditions
- Central Nervous System Neoplasms, Meningeal Neoplasms, Meningioma, +9 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States
Clinical trial condition
Recurrent Meningioma
Explore clinical trials studying Recurrent Meningioma. Study availability and eligibility vary by location and protocol.
8 public trials
6 recruiting studies
Recurrent Meningioma trial results
NCT07150806
- Conditions
- Central Nervous System Neoplasms, Meningeal Neoplasms, Meningioma, +8 more
- Locations
-
- Ohio State University Comprehensive Cancer Center Columbus, Ohio, United States
NCT02523014
- Conditions
- Central Nervous System Neoplasms, Intracranial Meningioma, Meningeal Neoplasms, +10 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
Recruiting
177Lu-DOTATATE for Recurrent Meningioma
NCT06326190
- Conditions
- Central Nervous System Neoplasms, Meningeal Neoplasms, Meningioma, +8 more
- Locations
-
- A.O Landeskrankenhaus - Innsbruck Universitaetsklinik Innsbruck, Austria
- Universitaetskliniken der Uni Wien - Universitaetsklinikum Wien - AKH unikliniken Vienna, Austria
- Centre Leon Berard Lyon, France
- CHU de Lyon - CHU Lyon - Hopital neurologique Pierre Wertheimer Lyon, France
NCT04082520
- Conditions
- Central Nervous System Neoplasms, Grade 1 Meningioma, Grade 2 Meningioma, +12 more
- Locations
-
- Mayo Clinic in Rochester Rochester, Minnesota, United States
NCT02847559
- Conditions
- Anaplastic (Malignant) Meningioma, Atypical Meningioma, Central Nervous System Neoplasms, +13 more
- Locations
-
- John Wayne Cancer Center at Providence St. John's Health Center Santa Monica, California, United States
- Miami Cancer Institute Miami, Florida, United States
- Piedmont Healthcare Atlanta, Georgia, United States
- Northwestern University Chicago, Illinois, United States
Active, not recruiting
Nivolumab and Multi-fraction Stereotactic Radiosurgery With or Without Ipilimumab in Treating Patients With Recurrent Grade II-III Meningioma
NCT03604978
- Conditions
- Central Nervous System Neoplasms, Grade 2 Meningioma, Grade 3 Meningioma, +10 more
- Locations
-
- Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
- City of Hope Comprehensive Cancer Center Duarte, California, United States
- UC San Diego Moores Cancer Center La Jolla, California, United States
- Los Angeles General Medical Center Los Angeles, California, United States
Active, not recruiting
Stereotactic Radiosurgery and Immunotherapy (Pembrolizumab) for the Treatment of Recurrent Meningioma
NCT04659811
- Conditions
- Central Nervous System Neoplasms, Grade I Meningioma, Adult, Grade II Meningioma, Adult, +11 more
- Locations
-
- University of California, San Francisco San Francisco, California, United States